Q2 FY2026 EarningsQ2 FY26 revenue of $8.4M exceeded the $7.6M consensus by 11.5%, driven by a 40% YoY surge in Direct Patient Services. However, bottom-line results missed significantly: normalized net income was -$0.51M vs. -$0.13M expected, and normalized EPS was -$0.07 vs. -$0.02 expected. Profitability was weighed down by a $0.9M credit loss allowance and $0.29M in legal costs related to debt restructuring, resulting in an EBIT miss of $0.29M compared to consensus.